ONCOLOGY REPORTS

简称 ONCOL REP ·GREECE ·出版周期 Monthly ·年均收录 878 篇

3.9

最新影响因子

5.60%

自引率

约54.23%

投稿难度

平均5.5月

审稿周期

期刊简介

ONCOLOGY REPORTS是一本专注于肿瘤学领域的国际学术期刊，ISSN号为1021-335X，由希腊出版商SPANDIDOS PUBL LTD出版，出版地为希腊雅典，出版周期为月刊。该期刊的影响因子根据最新数据在2-3之间波动，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学大类3区或4区。杂志的发文特点涵盖肿瘤学基础与临床研究的广泛领域，包括肿瘤分子机制、诊断、治疗及预后等，尤其关注实验肿瘤学和转化医学研究。其质量表现为审稿较严格，但近年来因发文量较大且自引率偏高，存在一定争议，可能被列入部分机构的预警名单，投稿时需注意学术风险。总体而言，该期刊适合需要快速发表中等影响力肿瘤学研究的学者，但需结合自身需求评估其学术认可度。

影响因子趋势

近期发表

Overcoming melanoma drug resistance: Mechanisms and clinical progress of oncolytic viruses combined with immune checkpoint inhibitors (Review) 2026-09-17

Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma 2026-09-16

[Corrigendum] The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer 2026-09-16

Pemetrexed increases BRCA1 protein stability and sensitizes TNBC cells to radiotherapy 2026-09-15

[Expression of Concern] RIP kinase‑mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin‑treated bladder cancer cells 2026-09-14

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis 2026-09-14

[Expression of Concern] In vitro and in vivo activities of an antitumor peptide HM‑3: A special dose‑efficacy relationship on an HCT‑116 xenograft model in nude mice 2026-09-10

Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non‑small cell lung cancer cells 2026-09-08

[Corrigendum] TGF‑β1 mediates epithelial to mesenchymal transition via the TGF‑β/Smad pathway in squamous cell carcinoma of the head and neck 2026-08-31

Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable non‑small cell lung cancer (Review) 2026-08-28